A case of multiple arterial thrombosis/ embolisms in a 74-year-old Caucasian man with no other cardiovascular risk factors who received Ad26.COV2-S vaccine 16 days before is reported. The unusual presentation required a longer diagnostic workup. The clinical manifestations and the therapy-specific response suggest an unusual presentation of Vaccine-induced immune thrombotic thrombocytopenia (VITT)
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of thr...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is diagnosed if there is venous or arteria...
A case of multiple arterial thrombosis/ embolisms in a 74-year-old Caucasian man with no other cardi...
We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a young man diagnos...
COVID-19 has significantly affected public health, social life, and economies worldwide. The only ef...
We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentl...
We describe the case of a 64 years-old woman admitted to the Emergency Department of the ASST-Spedal...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
While vaccination is the single most effective intervention to drastically reduce severe disease and...
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical th...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) with venous thrombosis is a rare complicat...
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of thr...
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus ...
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agen...
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of thr...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is diagnosed if there is venous or arteria...
A case of multiple arterial thrombosis/ embolisms in a 74-year-old Caucasian man with no other cardi...
We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a young man diagnos...
COVID-19 has significantly affected public health, social life, and economies worldwide. The only ef...
We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentl...
We describe the case of a 64 years-old woman admitted to the Emergency Department of the ASST-Spedal...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
While vaccination is the single most effective intervention to drastically reduce severe disease and...
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical th...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) with venous thrombosis is a rare complicat...
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of thr...
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus ...
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agen...
The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has approved the use of thr...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is diagnosed if there is venous or arteria...